Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.

  • Authors:
    • R Zagozdzon
    • J Golab
    • K Mucha
    • B Foroncewicz
    • M Jakobisiak
  • View Affiliations

  • Published online on: December 1, 1999     https://doi.org/10.3892/ijmm.4.6.645
  • Pages: 645-653
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The early clinical trials with interleukin-12 (IL-12) have demonstrated substantial toxicity of this cytokine. One way to resolve this problem would be to find other antitumor agents, e.g. chemotherapeutics, synergistically interacting with IL-12. However, analysis of the recent reports on this topic leads to the conclusion that the antitumor effects achieved in such combination treatments are dependent not only on the drug applied but also on the tumor model used. We described previously lack of the potentiation of antitumor effects in combination treatment with IL-12 and paclitaxel in a murine leukemia L1210 model. We investigated whether such treatment could bring therapeutical benefit by using the murine melanoma MmB16 model. significant potentiation of antitumor effects in combination treatment with IL-12 and paclitaxel was observed. These results suggest that combination of IL-12 and paclitaxel could be beneficial in the treatment of certain types of tumors.

Related Articles

Journal Cover

Dec 1999
Volume 4 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zagozdzon R, Golab J, Mucha K, Foroncewicz B and Jakobisiak M: Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.. Int J Mol Med 4: 645-653, 1999
APA
Zagozdzon, R., Golab, J., Mucha, K., Foroncewicz, B., & Jakobisiak, M. (1999). Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.. International Journal of Molecular Medicine, 4, 645-653. https://doi.org/10.3892/ijmm.4.6.645
MLA
Zagozdzon, R., Golab, J., Mucha, K., Foroncewicz, B., Jakobisiak, M."Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.". International Journal of Molecular Medicine 4.6 (1999): 645-653.
Chicago
Zagozdzon, R., Golab, J., Mucha, K., Foroncewicz, B., Jakobisiak, M."Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.". International Journal of Molecular Medicine 4, no. 6 (1999): 645-653. https://doi.org/10.3892/ijmm.4.6.645